8/25/23 19:04  | 8/25/23  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -118 | 1.53 | 0 | -77 | -5 | 1,560 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/23 21:06  | 8/18/23  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -93 | 1.66 | 0 | -56 | -4 | 1,495 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/11/23 19:24  | 8/11/23  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -60 | 1.44 | 0 | -41 | -3 | 1,410 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/23 19:05  | 8/4/23  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -58 | 1.10 | 0 | -53 | -4 | 1,310 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/16/22 18:57  | 5/13/22  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -211 | 1.19 | 0 | -178 | -17 | 897 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/6/22 17:08  | 1/5/22  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -25 | 3.59 | 0 | -7 | -1 | 734 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/4/22 17:07  | 1/3/22  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -14 | 3.67 | 0 | -4 | -1 | 723 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/20/21 18:11  | 7/19/21  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -68 | 5.43 | 0 | -13 | -2 | 718 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/14/21 18:43  | 5/13/21  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -304 | 6.40 | 0 | -47 | -6 | 705 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/21 16:26  | 1/6/21  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -2,319 | 8.92 | 0 | -260 | -28 | 655 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/6/21 16:37  | 1/5/21  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -96 | 10.56 | 0 | -9 | -2 | 415 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/5/21 17:33  | 1/4/21  | PGEN | Precigen, Inc. | VA | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | S.d | -54 | 10.16 | 0 | -5 | -1 | 407 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/21/20 18:40  | 7/20/20  | PGEN | Precigen, Inc. | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | DO | P,CEO | S.d | -56 | 4.58 | 0 | -12 | -3 | 402 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/20 16:04  | 5/15/20  | PGEN | Precigen, Inc. | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,CEO | S.d | -516 | 2.37 | 0 | -218 | -36 | 389 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/2/20 16:37  | 4/1/20  | PGEN | Precigen, Inc. | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,CEO | S.d | -16 | 3.01 | 0 | -5 | -5 | 107 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/20 17:13  | 1/6/20  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,CEO | S.d | -39 | 5.83 | 0 | -7 | -6 | 98 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/6/20 16:16  | 1/3/20  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,CEO | S.d | -22 | 5.77 | 0 | -4 | -4 | 87 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/20 16:32  | 1/2/20  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,CEO | S.d | -27 | 5.60 | 0 | -5 | -6 | 81 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/2/19 17:25  | 10/1/19  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,Precig | S.d | -28 | 5.50 | 0 | -5 | -7 | 72 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/19/19 17:21  | 7/18/19  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,Precig | S.d | -63 | 7.47 | 0 | -8 | -12 | 62 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/2/19 19:12  | 7/1/19  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,Precig | S.d | -37 | 7.76 | 0 | -5 | -10 | 46 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/4/19 18:46  | 1/3/19  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen |  | O | P,Precig | S.d | -27 | 7.07 | 0 | -4 | -15 | 23 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/19/18 18:03  | 7/18/18  | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Sabzevari Helen | MD | O | P,Precig | S.d | -122 | 14.54 | 0 | -8 | -34 | 17 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |